Clinical Trial Update: Extension of Phase 3 Gene Therapy for Painful Diabetic Neuropathy [Phase 3]

View source ↗

Summary

Extension of a Phase 3 gene therapy trial for painful diabetic neuropathy; the study completed and results were posted in March 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Painful Diabetic Neuropathy

Drugs mentioned

• Helixmith gene therapy

Snippet

Sponsor: Helixmith Co., Ltd. | Conditions: Painful Diabetic Neuropathy, Diabetic Neuropathy, Painful | Phase 3 | Status: COMPLETED | Results posted: 2023-03-08